BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 2153454)

  • 21. Interaction of melanin-concentrating hormone (MCH), neuropeptide E-I (NEI), neuropeptide G-E (NGE), and alpha-MSH with melanocortin and MCH receptors on mouse B16 melanoma cells.
    Hintermann E; Tanner H; Talke-Messerer C; Schlumberger S; Zumsteg U; Eberle AN
    J Recept Signal Transduct Res; 2001 Feb; 21(1):93-116. PubMed ID: 11693176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of an alpha-melanocyte-stimulating hormone analogue to improve alpha-melanocyte-stimulating hormone receptor binding assay in human melanoma.
    Libert A; Ghanem G; Arnould R; Lejeune FJ
    Pigment Cell Res; 1989; 2(6):510-8. PubMed ID: 2557606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel DOTA-alpha-melanocyte-stimulating hormone analog for metastatic melanoma diagnosis.
    Froidevaux S; Calame-Christe M; Tanner H; Sumanovski L; Eberle AN
    J Nucl Med; 2002 Dec; 43(12):1699-706. PubMed ID: 12468522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radioreceptor assay for alpha-MSH using mouse B16 melanoma cells+.
    Siegrist W; Oestreicher M; Stutz S; Girard J; Eberle AN
    J Recept Res; 1988; 8(1-4):323-43. PubMed ID: 2838620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calmodulin-binding peptides interfere with melanocyte-stimulating hormone receptor activity and stimulate adenosine 3',5'-monophosphate production in M2R mouse melanoma cells.
    Eshel Y; Salomon Y
    Endocrinology; 1994 Jan; 134(1):177-85. PubMed ID: 8275931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulation of S91 melanoma tyrosinase activity by superpotent alpha-melanotropins.
    Marwan MM; Abdel Malek ZA; Kreutzfeld KL; Hadley ME; Wilkes BC; Hruby VJ; Castrucci AM
    Mol Cell Endocrinol; 1985 Jul; 41(2-3):171-7. PubMed ID: 3926559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radioiodination of rhenium cyclized alpha-melanocyte-stimulating hormone resulting in enhanced radioactivity localization and retention in melanoma.
    Cheng Z; Chen J; Quinn TP; Jurisson SS
    Cancer Res; 2004 Feb; 64(4):1411-8. PubMed ID: 14973076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stable expression of the human MSH receptor in a mouse melanoma cell line.
    Chluba-de Tapia J; Bagutti C; Wikberg JS; Chhajlani V; Eberle AN
    J Recept Signal Transduct Res; 1995; 15(1-4):43-53. PubMed ID: 8903930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for the internalization of [125I-Tyr2, Nle4, D-Phe7] alpha-MSH following binding to the MSH receptor of B16 murine melanoma cells.
    Adams G; Olivier GW; Branch SK; Moss SH; Notarianni LJ; Pouton CW
    Ann N Y Acad Sci; 1993 May; 680():440-1. PubMed ID: 8390163
    [No Abstract]   [Full Text] [Related]  

  • 30. Induction of constitutive melanogenesis in amelanotic mouse melanoma cells by transfection of the human melanocortin-1 receptor gene.
    Chluba-de Tapia J; Bagutti C; Cotti R; Eberle AN
    J Cell Sci; 1996 Aug; 109 ( Pt 8)():2023-30. PubMed ID: 8856498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melanotropic peptide-conjugated beads for microscopic visualization and characterization of melanoma melanotropin receptors.
    Sharma SD; Jiang J; Hadley ME; Bentley DL; Hruby VJ
    Proc Natl Acad Sci U S A; 1996 Nov; 93(24):13715-20. PubMed ID: 8943000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneity of the MSH receptor among B16 murine melanoma subclones.
    SolcĂ  FF; Salomon Y; Eberle AN
    J Recept Res; 1991; 11(1-4):379-90. PubMed ID: 1653343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Desensitization of melanotropin receptors in COS-7 cells.
    Polgar WE; Bitler CM; Toll L
    Life Sci; 1996; 58(15):1223-9. PubMed ID: 8614275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small-animal PET of melanocortin 1 receptor expression using a 18F-labeled alpha-melanocyte-stimulating hormone analog.
    Cheng Z; Zhang L; Graves E; Xiong Z; Dandekar M; Chen X; Gambhir SS
    J Nucl Med; 2007 Jun; 48(6):987-94. PubMed ID: 17504880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced binding and inertness to dehalogenation of alpha-melanotropic peptides labeled using N-succinimidyl 3-iodobenzoate.
    Garg PK; Alston KL; Welsh PC; Zalutsky MR
    Bioconjug Chem; 1996; 7(2):233-9. PubMed ID: 8983345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA.
    Chhajlani V; Wikberg JE
    FEBS Lett; 1992 Sep; 309(3):417-20. PubMed ID: 1516719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptional induction of the melanocyte-stimulating hormone receptor in brain metastases of murine K-1735 melanoma.
    Radinsky R; Beltran PJ; Tsan R; Zhang R; Cone RD; Fidler IJ
    Cancer Res; 1995 Jan; 55(1):141-8. PubMed ID: 7805024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A selective protein kinase C inhibitor (CGP 41251) positively and negatively modulates melanoma cell MSH receptors.
    Siegrist W; Sauter P; Eberle AN
    J Recept Signal Transduct Res; 1995; 15(1-4):283-96. PubMed ID: 8903945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term and residual melanotropin-stimulated tyrosinase activity in S91 melanoma cells is density dependent.
    Abdel Malek ZA; Kreutzfeld KL; Hadley ME; Bregman MD; Hruby VJ; Meyskens FL
    In Vitro Cell Dev Biol; 1986 Feb; 22(2):75-81. PubMed ID: 3081484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors.
    Haskell-Luevano C; Nikiforovich G; Sharma SD; Yang YK; Dickinson C; Hruby VJ; Gantz I
    J Med Chem; 1997 May; 40(11):1738-48. PubMed ID: 9171884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.